FDA approves hepatitis B drug

The FDA has approved Tyzeka for hepatitis B, a drug developed by Idenix and Novartis. Tyzeka is expected to treat symptoms of the disease. It joins six other meds approved for HBV.

- here's the report on Tyzeka from EarthTimes